These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30315488)

  • 41. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
    Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
    Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Willingness to pay for chronic disease management services provided by primary care nurses.
    Park H; Yoon J
    Hum Resour Health; 2024 Jul; 22(1):49. PubMed ID: 38978050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Searching for a better willingness to pay elicitation method in rural Nigeria: the binary question with follow-up method versus the bidding game technique.
    Onwujekwe O
    Health Econ; 2001 Mar; 10(2):147-58. PubMed ID: 11252045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.
    Greenberg D; Bakhai A; Neumann PJ; Cohen DJ
    Health Policy; 2004 Nov; 70(2):207-16. PubMed ID: 15364150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity to scale of willingness-to-pay within the context of menorrhagia.
    Sanghera S; Frew E; Gupta JK; Kai J; Roberts TE
    Health Expect; 2017 Apr; 20(2):232-242. PubMed ID: 26914494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A questionnaire survey on patients' willingness to pay with reference to the waiting time of public in-vitro fertilization treatment in Hong Kong.
    Lai SF; Choi SN; Ho YB; Hung WY; Lam MT; Law T; Ng YT; Tam CT; Wan SF; Li R; Leung WC; Yeung W; Ng E
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():430-436. PubMed ID: 33550218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos.
    Papadopoulou A; Mason H; Donaldson C
    Appl Health Econ Health Policy; 2024 Nov; 22(6):871-883. PubMed ID: 39162993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Social and private benefits of assisted reproductive technology: a national survey-based evaluation in Israel.
    Gonen LD
    J Comp Eff Res; 2016 Jan; 5(1):49-63. PubMed ID: 26698829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China.
    Xiao J; Wu Y; Wang M; Ma Z
    Appl Health Econ Health Policy; 2022 May; 20(3):417-429. PubMed ID: 35001293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do divergences between stated and actual willingness to pay signify the existence of bias in contingent valuation surveys?
    Onwujekwe O; Hanson K; Fox-Rushby J
    Soc Sci Med; 2005 Feb; 60(3):525-36. PubMed ID: 15550301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are children rational decision makers when they are asked to value their own health? A contingent valuation study conducted with children and their parents.
    Guerriero C; Cairns J; Bianchi F; Cori L
    Health Econ; 2018 Feb; 27(2):e55-e68. PubMed ID: 28901604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south-east Nigeria.
    Mbachu C; Okoli C; Onwujekwe O; Enabulele F
    Health Expect; 2018 Feb; 21(1):270-278. PubMed ID: 28805985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan.
    Liu JT; Hammitt JK; Wang JD; Liu JL
    Health Econ; 2000 Jun; 9(4):319-26. PubMed ID: 10862075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
    Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Public's Willingness to Pay Towards a Medical Device for Detecting Foot Ulceration in People with Diabetes.
    Yang F; Gannon B; Weightman A
    Appl Health Econ Health Policy; 2018 Aug; 16(4):559-567. PubMed ID: 29948927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The contingency of contingent valuation. How much are people willing to pay against Alzheimer's disease?
    Nocera S; Bonato D; Telser H
    Int J Health Care Finance Econ; 2002 Sep; 2(3):219-40. PubMed ID: 14625942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scope and scale insensitivities in a contingent valuation study of risk reductions.
    Norinder A; Hjalte K; Persson U
    Health Policy; 2001 Aug; 57(2):141-53. PubMed ID: 11395179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method.
    Eden M; Payne K; Combs RM; Hall G; McAllister M; Black GC
    Br J Ophthalmol; 2013 Aug; 97(8):1051-6. PubMed ID: 23743435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inter-rater and test-retest reliability of three contingent valuation question formats in south-east Nigeria.
    Onwujekwe O; Fox-Rushby J; Hanson K
    Health Econ; 2005 May; 14(5):529-36. PubMed ID: 15386652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.